A detailed history of Rothschild Investment Corp transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Rothschild Investment Corp holds 10,000 shares of ADPT stock, worth $46,700. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Holding current value
$46,700
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 16, 2023

BUY
$5.07 - $8.44 $50,700 - $84,400
10,000 New
10,000 $55,000
Q4 2021

Jan 24, 2022

SELL
$25.17 - $36.85 $151,020 - $221,100
-6,000 Closed
0 $0
Q3 2021

Oct 12, 2021

BUY
$30.02 - $39.87 $30,020 - $39,870
1,000 Added 20.0%
6,000 $204,000
Q1 2021

Apr 15, 2021

BUY
$37.26 - $67.74 $186,300 - $338,700
5,000 New
5,000 $201,000
Q4 2020

Jan 25, 2021

SELL
$45.01 - $65.47 $315,070 - $458,290
-7,000 Closed
0 $0
Q3 2020

Oct 22, 2020

BUY
$35.79 - $48.81 $250,530 - $341,670
7,000 New
7,000 $340,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $667M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Rothschild Investment Corp Portfolio

Follow Rothschild Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment Corp , based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment Corp with notifications on news.